MedGenome

10/06/2026

This National Cancer Survivors Month, we recognize the resilience, strength, and determination of cancer survivors, and the people who stand beside them through every step of their journey, inspiring hope for many others.

As part of , MedGenome's cancer awareness initiative, our latest documentary film follows the journey of a cancer survivor whose treatment path was transformed by a critical genomic insight that helped her overcome the disease and gave her a second chance at life, highlighting the power of precision medicine in enabling more informed clinical decisions. These stories remind us of what is possible when scientific expertise and human perseverance come together.

Watch the film here: https://www.youtube.com/watch?v=FuEszhte5w0

The film features perspectives from Dr. Bharat Bhosale, who played a key role in the patient's treatment journey.

09/06/2026

MedGenome is excited to share our recent publication in the Journal of Fetal Medicine on the incidental identification of molar pregnancy during routine Maternal Cell Contamination (MCC) testing.

MCC testing is typically performed to ensure the accuracy of prenatal genetic results. However, our experience highlights how careful interpretation of STR patterns can reveal rare cases of complete molar pregnancy, demonstrating that routine quality checks can sometimes uncover clinically significant findings.
This study highlights the expanded diagnostic potential of MCC testing in prenatal genetics.

Read the full study here: https://thieme-connect.com/products/ejournals/abstract/10.1055/s-0046-1817785

08/06/2026

Genetic conditions often require specialised expertise for accurate diagnosis, management, and family guidance. MedGenome's Centre for Advanced Genomics in Pune offers comprehensive clinical genetics services under the leadership of Dr. Chaitanya Datar, Clinical & Metabolic Geneticist with 18+ years of experience.

From rare and undiagnosed disorders to prenatal genetics, pediatric genetic conditions, molecular diagnostics, and cancer genomics, patients can access expert care and personalised genetic insights—all under one roof.

📍 Pune
📞 For appointments & referrals: 9187219738

MedGenome is a global genomics diagnostics company and home to South Asia’s largest CAP-accredited genetic testing lab. With 1300+ tests across oncology, rare diseases, reproductive health and more, we support accurate diagnosis and better patient care.

03/06/2026

MedGenome CFO Mr. Surajit Chakrabartty participated in an insightful discussion at the BW Healthcare Excellence Summit & Awards 2026 held in Bengaluru.

In the panel discussion on “Where Is Smart Money Betting in Healthcare?”, he engaged with industry leaders on innovation, investment, and growth in the Indian healthcare sector: https://tinyurl.com/np7ayrf5

Mr. Chakrabartty shared his insights on the evolution of India’s healthcare ecosystem, highlighting its hyperlocal nature, with patients increasingly seeking healthcare services closer to home. He also reflected on the significant advances in genomics over the past decade, emphasizing the need to further strengthen innovation capabilities, research infrastructure, and funding support to drive better patient outcomes.

On the panel, Mr. Chakrabartty was joined by Mr. Raj Gore, Operating Partner, Advent, and Mr. Abhishek Yadav, Managing Director, Quadria Capital. The session was moderated by Dr. Swati Bhat, Director, IPSC India, Bangalore.

Thank you to Mr. Harbinder and BW Healthcare World team for the opportunity to be part of this engaging event.

31/05/2026

To know more about this test: 🌐https://tinyurl.com/2vdytk75 📞1800 296 9696

To***co remains the leading preventable risk factor for lung cancer. But when cancer is diagnosed, understanding its genomic profile can be critical for guiding treatment decisions.

MedGenome's Lung Cancer Duo Test offers comprehensive genomic profiling to help identify actionable alterations and support precision oncology.

***coDay

28/05/2026

What if the answers to complex neurological and developmental conditions were hidden in just 1–2% of our DNA?

In this insightful video, Dr. C P Ravi Kumar explains how Whole Exome Sequencing (WES) is transforming the diagnosis of rare and unexplained genetic disorders. From identifying de novo variants to helping families find clarity, WES is enabling more informed clinical decisions and bringing much-needed peace of mind to parents navigating uncertainty.

As genetic science advances, timely and accurate diagnosis is becoming a critical part of personalised care and better treatment pathways.

Watch the full video to understand how genomics is shaping the future of healthcare.

27/05/2026

Featured in Times Now for World Thalassemia Day: https://tinyurl.com/yh49945h

Dr. Thenral S. Geetha, Principal Scientist - Inherited Disease Genomics, MedGenome, highlighted the burden of Thalassemia in India, explaining the complexities of the condition and underscoring the importance of genetic testing in reducing the burden of inherited blood disorders in the country.

Reinforcing the need for greater awareness and access to genetic testing, Dr. Priya Kadam, Director - Reproductive Genomics, MedGenome, shared a powerful clinical example of a carrier couple, whom genetic testing helped navigate pregnancy risks, make informed reproductive choices, and welcome a healthy baby.

As advances in genomics continue to transform healthcare, early screening and informed intervention can play a critical role in enabling better outcomes for individuals and families.

25/05/2026

Know more about this test: 🌐https://tinyurl.com/mrd6syzu 📞1800 296 9696

Every thyroid nodule tells a different story. Understanding its molecular profile can help guide more informed clinical decisions.

MedGenome’s ThyroTrack leverages advanced genomic insights to support accurate thyroid nodule risk assessment, helping clinicians distinguish cases that may need immediate attention from those that can be managed conservatively.

Empowering precision-led care with deeper diagnostic confidence.

21/05/2026

Reinforcing our commitment to delivering integrated diagnostic solutions that address the healthcare needs in Western India.

Read here: https://health.economictimes.indiatimes.com/news/diagnostics/medgenome-acquires-majority-stake-in-sdrc-to-expand-integrated-diagnostics-footprint/131193694

We are pleased to announce that MedGenome has made a majority investment in Siddhi Diagnostics & Research Centre (SDRC), an established and trusted diagnostic imaging service provider with three decades of expertise and a strong presence across Mumbai western suburbs.

Bringing together advanced healthcare capabilities, this collaboration strengthens our comprehensive portfolio, offering clinicians and patients seamless access to integrated healthcare solutions, enabling holistic and accurate diagnoses and improved patient outcomes.

19/05/2026

We are delighted to announce that Medcare Diagnostics, Mumbai’s leading imaging and nuclear medicine services company, and a part of MedGenome’s integrated diagnostics ecosystem, has launched a new centre in Navi Mumbai. The centre houses state of the art medical equipment including Superconducting 3T MRI, PET MRI Fusion, TOF PET CT, 4D Ultra Sonography, and 3D Bone Densitometry.

With MedGenome’s advanced capabilities in genomic diagnostics and Medcare’s expertise in imaging and nuclear medicine services, we are steadily enabling more comprehensive diagnostics services aimed at enabling deeper clinical insights and precise decision-making.